It seems that a significant step has been taken in the stem cell based therapies in the field of heart diseases, as a team of researchers from the Monash University has come out to reveal how embryonic stem cells can be used to develop human heart cells.

So far, it was known that extensive research work was halted by the absence of a consistent supply of heart cells for trials, but with this report, now it's being hoped that a lot could be done to ensure that research and development in the field of heart diseases is not plagues at moment of time.

"We linked a green fluorescent marker - originally from a jelly-fish - to a gene found in heart cells, causing them to glow", said Dr. David Elliott who along with Professors Andrew Elefanty and Ed Stanley of Monash Immunology and Stem Cell Laboratories was leading the study.

The study was told to have got financial backing from Australian Stem Cell Centre, the National Health and Medical Research Council of Australia, the Heart Foundation and Victorian State Government.

As the team managed to demarcate the heart cells, it's being believed that the targeted heart cells would be able to stimulate extensive research now.

Apparently, the team is satisfied with the results as the efforts of ten long years by the world-leading team at Monash has finally given the desired results.